Next earnings date: 6 Oct 2025
Accolade, Inc. – NASDAQ:ACCD
Accolade stock price today
$7.02
+3.47
+98.31%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
Accolade stock price monthly change
+2.31%
month
Accolade stock price quarterly change
+2.31%
quarter
Accolade stock price yearly change
-71.64%
year
Accolade key metrics
Market Cap | 269.39M |
Enterprise value | 715.63M |
P/E | -2.18 |
EV/Sales | 1.99 |
EV/EBITDA | -1.90 |
Price/Sales | 2.80 |
Price/Book | 2.06 |
PEG ratio | 0.17 |
EPS | -0.68 |
Revenue | 401.06M |
EBITDA | -70.78M |
Income | -49.99M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -129.59% |
Oper. margin | -129.13% |
Gross margin | 46.5% |
EBIT margin | -129.13% |
EBITDA margin | -17.65% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAccolade stock price history
Accolade stock forecast
Accolade financial statements
| Nov 2021 | 83.45M | 22.50M | 26.97% |
|---|---|---|---|
| Feb 2022 | 93.75M | -34.55M | -36.86% |
| Feb 2023 | 99.02M | -30.43M | -30.73% |
| Feb 2024 | 124.83M | -7.50M | -6.01% |
| Aug 2025 | 132.62M | -30.29M | -22.84% |
|---|---|---|---|
| Aug 2025 | 136.29M | -20.55M | -15.08% |
| Aug 2025 | 121.75M | -28.32M | -23.26% |
| Nov 2025 | 136.87M | -24.62M | -17.99% |
Analysts Price target
Financials & Ratios estimates
| 2024-10-08 | -0.45 | -0.3 |
|---|
| Aug 2022 | 931684000 | 425.37M | 45.66% |
|---|---|---|---|
| Nov 2022 | 913791000 | 427.83M | 46.82% |
| Feb 2023 | 903069000 | 429.28M | 47.54% |
| Feb 2024 | 788151000 | 342.68M | 43.48% |
| Nov 2021 | -21.42M | 721K | 2.68M |
|---|---|---|---|
| Feb 2022 | -2.28M | -532K | 2.68M |
| Feb 2023 | -2.55M | -2.41M | 418K |
| Feb 2024 | 5.95M | -53.25M | 3.00M |
Accolade alternative data
| Aug 2023 | 2,370 |
|---|---|
| Sep 2023 | 2,370 |
| Oct 2023 | 2,370 |
| Nov 2023 | 2,370 |
| Dec 2023 | 2,370 |
| Jan 2024 | 2,370 |
| Feb 2024 | 2,370 |
| Mar 2024 | 2,370 |
| Apr 2024 | 2,370 |
| May 2024 | 2,400 |
| Jun 2024 | 2,400 |
| Jul 2024 | 2,400 |
Accolade other data
76.60%
-3.67%
of ACCD is owned by hedge funds
133
-18
53.98M
-1.99M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 717 |
| Mar 2024 | 0 | 2730 |
| Apr 2024 | 0 | 2820 |
| May 2024 | 0 | 2597 |
| Oct 2024 | 0 | 1789 |
| Nov 2024 | 0 | 5022 |
| Dec 2024 | 0 | 31651 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | CAVANAUGH ROBERT N officer: President | Common Stock | 214 | $3.62 | $775 | ||
Sale | BARNES STEPHEN H. officer: Chief Financial Officer | Common Stock | 222 | $3.62 | $804 | ||
Sale | SINGH RAJEEV director, officer.. | Common Stock | 667 | $3.62 | $2,416 | ||
Option | CAVANAUGH ROBERT N officer: President | Common Stock | 710 | N/A | N/A | ||
Option | CAVANAUGH ROBERT N officer: President | Restricted Stock Units | 710 | N/A | N/A | ||
Option | BARNES STEPHEN H. officer: Chief Financial Officer | Common Stock | 770 | N/A | N/A | ||
Option | BARNES STEPHEN H. officer: Chief Financial Officer | Restricted Stock Units | 770 | N/A | N/A | ||
Option | HILTON MICHAEL W director | Common Stock | 184 | N/A | N/A | ||
Option | HILTON MICHAEL W director | Restricted Stock Units | 184 | N/A | N/A | ||
Option | SINGH RAJEEV director, officer.. | Common Stock | 1,650 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2025 27 Jun 2024 | Q1 2025 Earnings Call Transcript |
| Q4 2024 25 Apr 2024 | Q4 2024 Earnings Call Transcript |
| Q3 2024 8 Jan 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 4 Oct 2023 | Q2 2024 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Rajeev Singh (1968) Chairman & Chief Executive Officer | $828,000 |
| Mr. Robert Cavanaugh (1969) Pres | $706,120 |
Mr. Stephen H. Barnes CPA (1971) Chief Financial Officer, Treasurer | $610,600 |
Accolade: Remain Confident That FY25 Guided Growth Is Achievable
Accolade: Consider Both Growth And Profitability
Accolade: Leveraging Tech To Deliver Accessible Healthcare
Accolade: Growth Reacceleration In FY25 Should Drive Valuation Upside
Accolade: FY25 And Long-Term Targets Inspire Confidence
Revisiting Signify Health
Accolade Impresses With Revenue Growth But Faces Operating Losses
Accolade: I May Add To My Position
100 Top Growth Stocks Down Big: These 2 Are Worth Considering
-
What's the price of Accolade stock today?
One share of Accolade stock can currently be purchased for approximately $7.02.
-
When is Accolade's next earnings date?
Accolade, Inc. is estimated to report earnings on Monday, 6 Oct 2025.
-
Does Accolade pay dividends?
No, Accolade does not pay dividends.
-
How much money does Accolade make?
Accolade has a market capitalization of 269.39M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.09% to 414.29M US dollars. Accolade made a loss 99.81M US dollars in net income (profit) last year or -$0.3 on an earnings per share basis.
-
What is Accolade's stock symbol?
Accolade, Inc. is traded on the NASDAQ under the ticker symbol "ACCD".
-
What is Accolade's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Accolade?
Shares of Accolade can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Accolade's key executives?
Accolade's management team includes the following people:
- Mr. Rajeev Singh Chairman & Chief Executive Officer(age: 57, pay: $828,000)
- Mr. Robert Cavanaugh Pres(age: 56, pay: $706,120)
- Mr. Stephen H. Barnes CPA Chief Financial Officer, Treasurer(age: 54, pay: $610,600)
-
How many employees does Accolade have?
As Jul 2024, Accolade employs 2,400 workers, which is 1% more then previous quarter.
-
When Accolade went public?
Accolade, Inc. is publicly traded company for more then 5 years since IPO on 1 Jul 2020.
-
What is Accolade's official website?
The official website for Accolade is accolade.com.
-
Where are Accolade's headquarters?
Accolade is headquartered at 660 West Germantown Pike, Plymouth Meeting, PA.
-
How can i contact Accolade?
Accolade's mailing address is 660 West Germantown Pike, Plymouth Meeting, PA and company can be reached via phone at +20 69 268100.
Accolade company profile:
Accolade, Inc.
accolade.comExchange:
NASDAQ
Full time employees:
2,400
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
660 West Germantown Pike
Plymouth Meeting, PA 19462
Plymouth Meeting, PA 19462
CIK: 0001481646
ISIN: US00437E1029
CUSIP: 00437E102
